News + Filings Transactions Holdings
All
13F
13D/G
Other
|
|
ORBIMED ADVISORS LLC
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 02/14/2023 |
SC 13G
| ORBIMED ADVISORS LLC reports a 7.9% stake in Verastem, Inc. |
| 02/14/2023 |
SC 13G
| ORBIMED ADVISORS LLC reports a 5.6% stake in ALX Oncology Holdings Inc. |
| 02/11/2022 |
SC 13G
| ORBIMED ADVISORS LLC reports a 14% stake in VectivBio Holding AG |
| 02/11/2022 |
SC 13G
| ORBIMED ADVISORS LLC reports a 7.5% stake in Sonendo, Inc. |
| 02/11/2022 |
SC 13G
| ORBIMED ADVISORS LLC reports a 3.9% stake in RxSight, Inc. |
| 02/11/2022 |
SC 13G
| ORBIMED ADVISORS LLC reports a 6% stake in Protara Therapeutics, Inc. |
| 02/11/2022 |
SC 13G
| ORBIMED ADVISORS LLC reports a 4.3% stake in Jounce Therapeutics, Inc. |
| 02/11/2022 |
SC 13G
| ORBIMED ADVISORS LLC reports a 8.9% stake in Gracell Biotechnologies Inc. |
| 02/11/2022 |
SC 13G
| ORBIMED ADVISORS LLC reports a 4.3% stake in Catalyst Biosciences, Inc. |
| 04/29/2021 |
SC 13G
| ORBIMED ADVISORS LLC reports a 16.8% stake in NeuroPace Inc. |
| 04/20/2021 |
SC 13G
| ORBIMED ADVISORS LLC reports a 13.8% stake in VectivBio Holding AG |
| 02/12/2021 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 02/12/2021 |
SC 13G
| ORBIMED ADVISORS LLC reports a 8.7% stake in Theravance Biopharma, Inc. |
| 02/12/2021 |
SC 13G
| ORBIMED ADVISORS LLC reports a 4.4% stake in Strongbridge Biopharma plc |
| 02/12/2021 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 02/12/2021 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 02/12/2021 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 02/12/2021 |
SC 13G
| ORBIMED ADVISORS LLC reports a 4.7% stake in Forte Biosciences, Inc. |
| 07/27/2020 |
SC 13G
| ORBIMED ADVISORS LLC reports a 3.6% stake in Pandion Therapeutics, Inc. |
| 02/18/2020 |
SC 13G
| ORBIMED ADVISORS LLC reports a 5.4% stake in Krystal Biotech, Inc. |
| 02/14/2020 |
SC 13G
| ORBIMED ADVISORS LLC reports a 5.4% stake in Krystal Biotech, Inc. |
| 02/14/2020 |
SC 13G
| ORBIMED ADVISORS LLC reports a 9.4% stake in MeiraGTx Holdings plc |
| 02/14/2020 |
SC 13G
| ORBIMED ADVISORS LLC reports a 4.6% stake in Applied Therapeutics, Inc. |
| 02/14/2020 |
SC 13G
| ORBIMED ADVISORS LLC reports a 8.4% stake in Crinetics Pharmaceuticals Inc. |
| 02/14/2020 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 02/14/2020 |
SC 13G
| ORBIMED ADVISORS LLC reports a 6.1% stake in Adverum Biotechnologies, Inc. |
| 11/12/2019 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 04/19/2019 |
SC 13G
| ORBIMED ADVISORS LLC reports a 9.8% stake in X4 PHARMACEUTICALS, INC. |
| 02/21/2019 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 02/12/2019 |
SC 13G
| ORBIMED ADVISORS LLC reports a 8% stake in Inspire Medical Systems, Inc. |
| 02/12/2019 |
SC 13G
| ORBIMED ADVISORS LLC reports a 5.6% stake in Deciphera Pharmaceuticals, Inc. |
| 02/12/2019 |
SC 13G
| ORBIMED ADVISORS LLC reports a 4.4% stake in Clovis Oncology, Inc. |
| 10/10/2018 |
SC 13G
| ORBIMED ADVISORS LLC reports a 6% stake in Arvinas, Inc. |
| 09/27/2018 |
SC 13G
| ORBIMED ADVISORS LLC reports a 11.1% stake in PRINCIPIA BIOPHARMA INC. |
|
|
|